Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence

被引:33
|
作者
Stelma, F. F. [1 ]
Smismans, A. [1 ]
Goossens, V. J. [1 ]
Bruggeman, C. A. [1 ]
Hoebe, C. J. P. A. [1 ,2 ]
机构
[1] Univ Hosp, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands
[2] S Limburg Publ Hlth Serv, Dept Infect Dis, Geleen, Netherlands
关键词
PREGNANCY;
D O I
10.1007/s10096-008-0635-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cytomegalovirus (CMV) and Parvovirus B19 infections acquired during pregnancy may result in developmental disabilities of the foetus. This study evaluates the occupational risk of these infections in female day care personnel. IgG seroprevalence was determined in 310 Dutch day care workers and 158 nursing school students. CMV seroprevalence was age-related, starting at 21% in those < 20 years and reaching 65% in those > 35 years. Between the ages of 20 and 24 years the CMV prevalence was higher in day care personnel than in controls, 50% versus 31% (p = 0.03). In the first 2 years of employment the risk of attracting CMV was significantly increased (ORadj = 3.80; p < 0.001) and the occupational risk was also increased (ORadj 2.19; p < 0.001). Parvovirus seropositivity (71-77%) was not related to age or working at a day care centre. In conclusion, an occupational risk was observed for CMV, but not for Parvovirus infection in female day care personnel.
引用
收藏
页码:393 / 397
页数:5
相关论文
共 50 条
  • [21] Risk factors for parvovirus B19 infection in pregnancy
    Valeur-Jensen, AK
    Pedersen, CB
    Westergaard, T
    Jensen, IP
    Lebech, M
    Andersen, PK
    Aaby, P
    Pedersen, BN
    Melbye, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (12): : 1099 - 1105
  • [22] Serologic study of human parvovirus B19 infection in pregnancy in Japan
    Yaegashi, N
    Niinuma, T
    Chisaka, H
    Uehara, S
    Okamura, K
    Shinkawa, O
    Tsunoda, A
    Moffatt, S
    Sugamura, K
    Yajima, A
    JOURNAL OF INFECTION, 1999, 38 (01) : 30 - 35
  • [23] Human parvovirus B19 seroprevalence in patients with congenital bleeding disorders
    Canales, M
    Pinilla, J
    Mateos, P
    Alvrez, M
    Jimenez, VM
    Martin, MP
    Hernandez, D
    Sanjurjo, MJ
    Quintana, M
    Villar, A
    Gago, J
    Cruchaga, S
    Magallon, M
    Navarro, FH
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1858 - P1858
  • [24] Epidemiologic study of human parvovirus B19 infection in East China
    Zhang, Lahong
    Cai, Chengsong
    Pan, Feng
    Hong, Liquan
    Luo, Xian
    Hu, Sha
    Xu, Jiali
    Chen, Zhaojun
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (07) : 1113 - 1119
  • [25] Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland
    Riipinen, Anita
    Sallmen, Markku
    Hedman, Lea
    Ojajarvi, Anneli
    Lindbohm, Marja-Liisa
    Meriluoto, Mira
    Surcel, Helja-Marja
    Taskinen, Helena
    Nuutila, Mika
    Karikoski, Riitta
    Hedman, Klaus
    Soderlund-Venermo, Maria
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 71 (12) : 836 - 841
  • [26] Diagnosis and management of human parvovirus B19 infection
    Ramirez, MM
    Mastrobattista, JM
    CLINICS IN PERINATOLOGY, 2005, 32 (03) : 697 - +
  • [27] Human parvovirus B19 infection in an immunocompromised host
    Pandey, Soumya
    CLINICAL CASE REPORTS, 2020, 8 (12): : 3609 - 3610
  • [28] RISKS ASSOCIATED WITH HUMAN PARVOVIRUS B19 INFECTION
    不详
    ARCHIVES OF DERMATOLOGY, 1989, 125 (04) : 475 - 480
  • [29] Human parvovirus B19 infection and antiphospholipid antibodies
    von Landenberg, Philipp
    Lehmann, Hartwig W.
    Modrow, Susanne
    AUTOIMMUNITY REVIEWS, 2007, 6 (05) : 278 - 285
  • [30] PROSPECTIVE-STUDY OF HUMAN PARVOVIRUS (B19) INFECTION IN PREGNANCY
    HALL, SM
    BMJ-BRITISH MEDICAL JOURNAL, 1990, 300 (6733): : 1166 - 1170